Sorrento Therapeutics Inc - Company Profile

All the sales intelligence you need on Sorrento Therapeutics Inc in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Sorrento Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Sorrento Therapeutics Inc.

Sorrento Therapeutics Inc: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 16+ results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	21 Mar 2022	Lorem
LoA Update: Sorrento’s fibromyalgia candidate has improved advancement chances after Phase I trial completes	03 Feb 2022	William Newton
Sorrento Therapeutics enrolls 60 of 80-patient Phase II target with abivertinib in COVID-19, with futility analysis of patient subset in potentially a month, CEO says	10 Feb 2021	Manasi Vaidya
Sorrento to file a COVID-19 IND application for mAb STI-1499 in late July or early August; 24-patient Phase I study to follow soon after, execs say	15 Jul 2020	Manasi Vaidya

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Sorrento Therapeutics Inc and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer